Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
13 authors.
Joaquim CarrerasDepartment of Pathology, School of Medicine, Tokai University, 143 Shimokasuya, Isehara 259-1193, Japan.ORCID 0000-0002-6129-8299
Yara Yukie KikutiDepartment of Pathology, School of Medicine, Tokai University, 143 Shimokasuya, Isehara 259-1193, Japan.
Shunsuke NagaseDepartment of Pathology, School of Medicine, Tokai University, 143 Shimokasuya, Isehara 259-1193, Japan.ORCID 0000-0002-6130-3879
Giovanna RoncadorMonoclonal Antibodies Unit, Spanish National Cancer Research Center (CNIO), Centro Nacional de Investigaciones Oncologicas, C/Melchor Fernandez Almagro, 3, 28029 Madrid, Spain.ORCID 0000-0002-9807-2875
Haruka IkomaDepartment of Pathology, School of Medicine, Tokai University, 143 Shimokasuya, Isehara 259-1193, Japan.
Atsushi ItoDepartment of Pathology, School of Medicine, Tokai University, 143 Shimokasuya, Isehara 259-1193, Japan.ORCID 0000-0003-3482-2742
Makoto OritaDepartment of Pathology, School of Medicine, Tokai University, 143 Shimokasuya, Isehara 259-1193, Japan.
Sakura TomitaDepartment of Pathology, School of Medicine, Tokai University, 143 Shimokasuya, Isehara 259-1193, Japan.
Yuki TanigakiDepartment of Pathology, School of Medicine, Tokai University, 143 Shimokasuya, Isehara 259-1193, Japan.ORCID 0009-0005-0542-2549
Akihisa UenoDepartment of Pathology, School of Medicine, Tokai University, 143 Shimokasuya, Isehara 259-1193, Japan.ORCID 0000-0001-9428-4128
Yusuke KondoDepartment of Pathology, School of Medicine, Tokai University, 143 Shimokasuya, Isehara 259-1193, Japan.
Naoya NakamuraDepartment of Pathology, School of Medicine, Tokai University, 143 Shimokasuya, Isehara 259-1193, Japan.
Yohei MasugiDepartment of Pathology, School of Medicine, Tokai University, 143 Shimokasuya, Isehara 259-1193, Japan.
Funding
Japan Society for the Promotion of Science 15K19061, 18K15100, 23K06454 and 25K10272Ministry of Education, Culture, Sports, Science and Technology 15K19061, 18K15100, 23K06454 and 25K10272
6 · The paper itself
Abstract
PubMed holds no abstract for this paper.
Indexed as
computer visiondiffuse large B-cell lymphomaDLBCLimage processingoverall survivalreactive lymphoid tissue
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
High Histological Entropy Is Correlated with Poor Overall Survival and Death Within the First 2 Years in Diffuse Large B-Cell Lymphoma. · full record | OpenQuestion